Bristol Myers takes on autoimmune diseases with cell therapy, plus new data from Cabaletta and Kyverna
Bristol Myers Squibb recently presented data for the first time from its clinical trial of a cell therapy for autoimmune diseases, which has quickly become …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.